 Thromboprophylaxis patients hip fractures prospective comparative study Org prospective assessor-blind trial thromboprophylactic effect safety heparinoid Org mixture low molecular-weight glycosaminoglycuronides patients hip fracture Prestudy biostatistical calculations need patients patients randomization majority postponed surgery Analyses patients intention-to-treat basis patients correct prophylaxis Diagnosis deep vein thrombosis bilateral phlebography postoperative days frequency deep vein thrombosis intention-to-treat basis Org group dextran group basis correct prophylaxis differences significant Two-month mortality rates equal groups fatal pulmonary emboli dextran group patients dextran group postoperative transfusions differences various hemorrhagic parameters Org thromboprophylactic effect patients hip fractures significant side effects